What is the dosage of Cimzia?

Cimzia is available in 2 dosages, including 200 mg Injection and 200 mg/ml Prefilled Syringe 1 ml

What does Cimzia treat?

Cimzia treats Rheumatoid Arthritis, Crohn Disease, Ankylosing Spondylitis and Psoriatic Arthritis

What is Cimzia made of?

Cimzia contains certolizumab pegol which is a Tumor Necrosis Factor Blocker

How is Cimzia administered?

Cimzia is administered as a Injectable

What is Cimzia mechanism of action?

Cimzia mechanism of action is Tumor Necrosis Factor Receptor Blocking Activity

Dosage & Administration Drug label Prior authorization Financial assistance

Patient education People also ask

Cimzia

(certolizumab pegol)

1 ML certolizumab pegol 200 MG/ML Prefilled Syringe [Cimzia]certolizumab pegol 200 MG Injection [Cimzia]

BLACK BOX WARNING

Dosage & administration

CIMZIA is administered by subcutaneous injection. The recommended initial dose of CIMZIA is 400 mg (given as two subcutaneous injections of 200 mg) ( 2).

Crohn's Disease ( 2.1)

* 400 mg initially and at Weeks 2 and 4. If response occurs, follow with 400 mg every four weeks

Rheumatoid Arthritis ( 2.2)

* 400 mg initially and at Weeks 2 and 4, followed by 200 mg every other week; for maintenance dosing, 400 mg every 4 weeks can be considered

Psoriatic Arthritis ( 2.3)

* 400 mg initially and at week 2 and 4, followed by 200 mg every other week; for maintenance dosing, 400 mg every 4 weeks can be considered.

Ankylosing Spondylitis ( 2.4)

* 400 mg (given as 2 subcutaneous injections of 200 mg each) initially and at weeks 2 and 4, followed by 200 mg every other week or 400 mg every 4 weeks.

Non-radiographic Axial Spondyloarthritis ( 2.5)

* 400 mg (given as 2 subcutaneous injections of 200 mg each) initially and at weeks 2 and 4, followed by 200 mg every other week or 400 mg every 4 weeks.

Plaque Psoriasis ( 2.6, 14.6)

* 400 mg (given as 2 subcutaneous injections of 200 mg each) every other week. For some patients (with body weight ≤ 90 kg), a dose of 400 mg (given as 2 subcutaneous injections of 200 mg each) initially and at Weeks 2 and 4, followed by 200 mg every other week may be considered.

drug label

Cimzia prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Cimzia prior authorization resources

Most recent Cimzia prior authorization forms

View By Payer

Verified: Oct 02, 2023Blue Cross Blue Shield of Michigan - FEP Cimzia Prior Authorization Form (Medical Benefit)

Verified: Sep 27, 2023Cigna - Cimzia Prior Authorization Form

Verified: Sep 26, 2023Blue Cross Blue Shield of Michigan - Cimzia Prior Authorization Form (Medical Benefit)

Verified: Sep 22, 2023Independence Health - Value Formulary Immune Modulating Therapy Prior Authorization Form

Verified: Sep 22, 2023Independence Health - Select Formulary Immune Modulating Therapy Prior Authorization Form

Verified: Sep 21, 2023Aetna - Cimzia Prior Authorization Form

Verified: Sep 19, 2023Aetna - Medicare Part B Cimzia Prior Authorization Form

PDFComplete Letter of Medical Necessity

PDFCoverage Authorization Request

PDFCIMplicity Enrollment & Benefits Verification Form: Rheumatology & GI

PDFCIMplicity Enrollment & Benefits Verification Form: Dermatology

Learn More

Benefits investigation

PDFCIMplicity Enrollment & Benefits Verification Form: Rheumatology & GI

PDFCIMplicity Enrollment & Benefits Verification Form: Dermatology

Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Learn More

financial assistance

Cimzia financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

PDFCIMplicity Enrollment & Benefits Verification Form: Dermatology

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

OTHERUCB Cares Foundation

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.